Urology & Nephrology Podcasts This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory.

GRACEcastUC101_Kidney_Dr. Pal on Surgery for Metastatic Kidney Cancer
http://cancerGRACE.org/... Dr. Sumanta (Monty) Pal, medical oncologist at City of Hope Cancer Center in Duarte, CA, describes the role of surgery in the treatment of metastatic kidney cancer. Author: cancergrace Added: 05/07/2013 (Source: Oncology Tube)
Source: Oncology Tube - May 7, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcastUC089_Kidney_Dr. Pal on Chemotherapy Role in Kidney Cancer Treatment
http://cancerGRACE.org/... Dr. Sumanta (Monty) Pal reviews the current role of chemotherapy in the treatment of kidney cancer. Author: cancergrace Added: 05/03/2013 (Source: Oncology Tube)
Source: Oncology Tube - May 3, 2013 Category: Cancer & Oncology Source Type: podcasts

Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
(Source: Johnson and Johnson Podcasts)
Source: Johnson and Johnson Podcasts - May 3, 2013 Category: Pharmaceuticals Source Type: podcasts

GRACEcastUC-030_Kidney_Dr. Pal on Kidney Mass Evaluation
Dr. Sumanta (Monty) Pal of City of Hope Cancer Center in Duarte, CA reviews a recommended approach to the workup of a kidney mass suspected to be a cancer. Author: cancergrace Added: 04/30/2013 (Source: Oncology Tube)
Source: Oncology Tube - April 30, 2013 Category: Cancer & Oncology Source Type: podcasts

Understanding Meds for CKD Patients
Jeffrey Berns talks about medication safety in patients and the importance of communicating to nonnephrologists the specific hazards in patients with kidney disease. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - April 22, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

AHA Survey: Women Still Don't Know of Their Danger
Ileana Pina talks about a new survey conducted by the American Heart Disease that shows more awareness of heart disease in women -- but there are still disparity gaps. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - April 22, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

Who Gets Kidney Stones
(Source: Mayo Clinic - Medical Edge Radio)
Source: Mayo Clinic - Medical Edge Radio - April 22, 2013 Category: Consumer Health Advice Authors: Mayo Clinic Source Type: podcasts

Sevelamer: A Phosphate Binder Friend With Benefits?
Jeffrey Berns discusses the phosphate binder sevelamer and suggests that anti-inflammatory or antioxidant effects might be an added benefit for patients with kidney disease. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - April 1, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts

#183: Mixed messages on new bleeding data with dabigatran; "high-potency" statins linked to acute kidney injury; dabigatran might cut hospital days vs standard anticoagulants in new AF; US supermarket chain giving away atorvastatin
Mixed messages on new bleeding data with dabigatran; "high-potency" statins linked to acute kidney injury; dabigatran might cut hospital days vs standard anticoagulants in new AF; US supermarket chain giving away atorvastatin (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - March 22, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts

Finasteride: No Survival Benefit
A new analysis of the Prostate Cancer Prevention Trial found no mortality difference after 15 years in men who took finasteride to prevent prostate cancer or a placebo, Dr. Gerald Chodak reports. (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - March 12, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

ADT in High-Risk Prostate Cancer: How to Advise Patients?
Dr. Gerald Chodak interprets findings from a new study comparing 18-month vs 36-month hormone therapy in high-risk prostate cancer patients. (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - March 4, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

Are You Joining an ESCO? Find Out if You Should
Jeffrey Berns reports on a CMS 5-year initiative, the formation of 15 ESRD Seamless Care Organizations (ESCOs). The goal: cost savings through coordinated care for patients on dialysis. Will it work? (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - March 1, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

Treating Localized Prostate CA Causes Functional Declines
A new study examines the long-term effects of treating localized prostate cancer, and clinicians need to inform patients of these outcomes, says Dr. Gerald Chodak. (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - February 22, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

Dr. Vincent Khoo on Oligometastatic prostate cancer
Prostate cancer is not a single disease. Oligometastatic disease is an emerging concept in prostate cancer, though it has been seen in other cancers such as, breast and liver. Dr. Vincent Khoo of the ... Author: vhsimons Added: 02/22/2013 (Source: Oncology Tube)
Source: Oncology Tube - February 22, 2013 Category: Cancer & Oncology Source Type: podcasts

Testosterone and Advanced prostate cancer
Dr. Nicola Mottet speaks to latest developments relative to testosterone and the promotion of more aggressive prostate cancer. Report from the European Multi-disciplinary Meeting on Urological Cancers Author: vhsimons Added: 02/21/2013 (Source: Oncology Tube)
Source: Oncology Tube - February 21, 2013 Category: Cancer & Oncology Source Type: podcasts

Tolvaptan and Liver Damage Warnings: Tip of the Iceberg?
Jeffrey Berns talks about the FDA warnings concerning liver damage with the use of tolvaptan, recently approved for polycystic kidney disease. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - February 21, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

Prostate Cancer Drug Combination Trial Shows Promise for Highly Advanced Disease
Dr. Raymond Lance, a urologic oncologist and researcher at Urology of Virginia, explains the results of a clinical trial investigating if two powerful approved medicines for metatstaic castration-resi... Author: patientpower Added: 02/19/2013 (Source: Oncology Tube)
Source: Oncology Tube - February 19, 2013 Category: Cancer & Oncology Source Type: podcasts

Tolvaptan: A New Weapon for a Tough Kidney Disease
This F1000 commentary reports on a study whose findings support the use of tolvaptan to slow the progression of autosomal dominant polycystic kidney disease (ADPKD). (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - February 14, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

Prostate Cancer Drug Combination Trial Shows Promise for Highly Advanced Disease
Dr. Raymond Lance, a urologic oncologist and researcher at Urology of Virginia, explains the results of a clinical trial investigating if two powerful approved medicines for metatstaic castration-resi... Author: patientpower Added: 02/13/2013 (Source: Oncology Tube)
Source: Oncology Tube - February 14, 2013 Category: Cancer & Oncology Source Type: podcasts

Huge Shift From EPO to Iron: Worrisome
Jeffrey Berns discusses the DOPPS results on anemia management: Erythropoietin use is way down and iron administration is way up; this is probably not a good thing. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - February 6, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

Proton Therapy Overhyped for Prostate Cancer?
New studies find that costly proton radiation therapy has no benefit over standard IMRT, so why are some urologists still singing its praises? Dr. Gerald Chodak discusses the issues. (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - January 30, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

eGFR: Remember, 'e' Stands for 'Estimated'
Jeffrey Berns discusses the challenge of staging chronic kidney disease on the basis of a single GFR value and why you should remember that it is an estimate only. (Source: Medscape Family Medicine Podcast)
Source: Medscape Family Medicine Podcast - January 29, 2013 Category: Primary Care Authors: Medscape Source Type: podcasts

Panel Ups Ante in PC Screening Controversy
Dr. Gerald Chodak discusses new guidance from a California expert panel regarding prostate cancer screening, along with implications for practicing urologists. (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - January 25, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

#174: Niacin/laropiprant products to be suspended; JNC 8, ATP 4 guidelines; new meta-analysis on sugar sparks old debate; two antihypertensives plus NSAID ups risk of acute kidney injury
Niacin/laropiprant products to be suspended; JNC 8, ATP 4 guidelines; new meta-analysis on sugar sparks old debate; two antihypertensives plus NSAID ups risk of acute kidney injury (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - January 18, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts

Tolvaptan: Exciting Progress for Polycystic Kidney Disease
In this international Skype conversation, Lynda Szczech and Donal O’Donoghue provide in-depth guidance on the current research and use of tolvaptan in autosomal dominant polycystic kidney disease. (Source: Medscape Family Medicine Podcast)
Source: Medscape Family Medicine Podcast - January 16, 2013 Category: Primary Care Authors: Medscape Source Type: podcasts

CKD and Heart Disease: It's a Factor -- Not a Marker
George Bakris talks to Paul Muntner via Skype about chronic kidney disease as a factor -- not a marker -- in cardiovascular disease. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - January 14, 2013 Category: Cardiology Authors: Medscape Source Type: podcasts

How Will Nephrologists Be Affected Post-Cliff?
Jeffrey Berns talks about the changes coming in 2013 after the fiscal cliff vote that will affect the economics of nephrologists, including fees and dialysis payments. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - January 10, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

New Nephrologists: Not Made in America
Jeffrey Berns discusses the challenges of filling nephrology fellowships now and -- more disturbing -- in the future. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - January 8, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

How To Avoid a Kidney Stone
(Source: Mayo Clinic - Medical Edge Radio)
Source: Mayo Clinic - Medical Edge Radio - January 8, 2013 Category: Consumer Health Advice Authors: Mayo Clinic Source Type: podcasts

Enzalutamide: New Weapon Against Metastatic Prostate Cancer
This F1000 commentary reports on enzalutamide, a novel antiandrogen in patients with metastatic prostate cancer. (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - January 4, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

iSBTc Annual Meeting - Highlights
The International Society for Biological Therapy of Cancer (iSBTc) Annual Meeting is holding its Annual Meeting at National Harbor, Washington, DC. Bill Bro, a kidney cancer survivor and CEO of the K... Author: SITC Added: 01/04/2013 (Source: Oncology Tube)
Source: Oncology Tube - January 4, 2013 Category: Cancer & Oncology Source Type: podcasts

Coming Soon: Nephrology's Very Own Fiscal Cliff
Jeff Berns talks about what lies ahead in 2013 for changes in bundled payments, including additions of new oral medications and the effects of lower use of erythropoiesis-stimulating agents. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - December 31, 2012 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

Tolvaptan: How Good Is It for Polycystic Kidney Disease?
Jeffrey Berns comments on the results presented at ASN 2012 on the effect of tolvaptan on autosomal dominant polycystic kidney disease. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - December 18, 2012 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

Predicting AKI in the Critically Ill With BCR
This F1000 commentary reports on a study whose findings do not support use of the BUN:creatinine ratio (BCR) to diagnose prerenal acute kidney in critically ill patients. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - December 14, 2012 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts